A fatal case of severe SLE complicated by invasive aspergillosis

Rheumatology International

Volumn 17, Issue 3, 1997, Pages 127-130

  Zuber, M ^a   Daus, H ^a   Koch, B ^a   Pfreundschuh, M ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Aspergillosis; Opportunistic infections; Pancytopenia; Systemic lupus erythematosus

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; FLUCONAZOLE; PREDNISOLONE;

ABDOMINAL PAIN; ADULT; ANTIBIOTIC THERAPY; ARTHRALGIA; ARTICLE; ARTIFICIAL VENTILATION; ASPERGILLOSIS; BRONCHOSCOPY; CASE REPORT; CLINICAL FEATURE; COUGHING; DYSPNEA; FEMALE; FEVER; HUMAN; PANCYTOPENIA; PNEUMONIA; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSBRONCHIAL BIOPSY; X RAY;

ADULT; AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; ASPERGILLOSIS; FATAL OUTCOME; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; OPPORTUNISTIC INFECTIONS;

EID: 0030679697     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002960050021     Document Type: Article

References (14)

1. Merrell M, Shulman LE (1955) Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus. J Chron Dis 1: 12-32
2. Fries JF, Weyl S, Holman HR (1974) Estimating prognosis in systemic lupus erythematosus. Am J Med 1974: 561-565
3. Abu-Shakra M, Urowitz MB, Gladman DD, Gough J (1995) Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. J Rheumatol 22: 1259-1264
4. Hellmann DB, Petri M, Whiting-O'Keefe Q (1987) Fatal infections in systemic lupus erythematosus: the role of opportunistic organism. Medicine 66: 341-348
5. Warnock DW (1991) Introduction to the management of fungal infection in the compromised patient. In: Warnock DW, Richardson MD (eds) Fungal infection in the compromised patient. Second Edn. John Wiley and Sons, Chichester, pp. 23-53
6. Rinaldo MG (1983) Invasive aspergillosis. Rev Infect Dis 5: 1061-1077
7. Berenguer J, Allende MC, Lee JW, Garrett K, Lymann C, Ali NM, Bacher J, Pizzo PA, Walsh TJ (1995) Pathogenesis of pulmonary aspergillosis. Granulocytopenia versus cyclosporine and methylprednisolone-induced immunosuppression. Am J Respir Crit Care Med 152: 1079-1086
8. Gonzales-Crespo MR, Gomez-Reino JJ (1995) Invasive Aspergillosis in Systemic Lupus Erythematosis. Sem Arthritis Rheum 24: 304-314
9. Colluzos J, Martinez E, Flores M, Mayo J (1994) Aspergillus pneumonia successfully treated with itraconazole in a patient with systemic lupus erythematosus. Clin Invest 72: 920-921
10. Katz A, Ehrenfeld M, Livneh A, Bank I, Gur H, Pauzner R, Many A, Langevitz P (1996) Aspergillosis in systemic lupus erythematosus. Sem Arthritis Rheum 26: 635-640
11. Staib F (1992) Problems associated with aspergilli and aspergillosis in the hospital. Eur J Hosp Pharm 2: 128-132
12. Georgiev VSt (1992) Treatment and development therapeutics in aspergillosis. 1. Amphotericin B and its derivatives. Respiration 59: 291-302
13. Georgiev VSt (1992) Treatment and development therapeutics in aspergillosis. 2. Azoles and other antifungal drugs. Respiration 59: 303-313
14. Como JA, Dismukes WE (1994) Oral azole drugs as systemic antifungal therapy. N Engl J Med 330: 263-272